Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2018
July 2018, Vol 8, No 7
July 2018, Vol 8, No 7
Updated NCCN Guidelines Expand Targeted Therapy Options for Patients with Metastatic NSCLC
By
Wayne Kuznar
NCCN Guideline Updates
,
National Comprehensive Cancer Network (NCCN)
Read More ›
Strategic Planning by Oncology Practices Can Provide a Roadmap to a Thriving Future
By
Elaine Estes
Practice Management
,
Strategic Planning
,
Practice Management
Strategic planning for oncology practices is more important today than ever before, with the oncology landscape rapidly evolving, driven by complex issues not encountered previously.
Read More ›
Will Oncologists Change Their Treatment Patterns Based on New Clinical Evidence?
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›
NCCN Updated Guideline Adds Treatment Options for HER2-Positive Breast Cancer, Emphasizing CDK4/CDK6 Inhibition in Hormone-Sensitive Disease
By
Wayne Kuznar
NCCN Guideline Updates
,
National Comprehensive Cancer Network (NCCN)
Read More ›
Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?
By
Meg Barbor, MPH
Survivorship
The incidence of sexual dysfunction in cancer survivors can be high and long lasting, but early discussion, evaluation, and treatment of sexual problems can improve sexual outcomes, reduce emotional distress, and facilitate recovery in survivors.
Read More ›
Oncologists Discuss Medical Marijuana with Patients but Are Not Sure About Its Efficacy
By
Clark Westfield
Medicinal Cannabis
Oncologists often discuss medical marijuana with their patients, and approximately 50% of them are recommending it as a treatment for cancer-related symptoms. However, many oncologists are unsure about the reasons for their recommendations, and whether marijuana will be an effective treatment, according to the results of a recent survey of oncologists regarding their knowledge, practices, and attitudes about medical marijuana.
Read More ›
Management of Acute Myeloid Leukemia with FLT3 Mutation
By
Meg Barbor, MPH
Leukemia
In April 2017, the FDA approved midostaurin (Rydapt) as the first tyrosine kinase inhibitor (TKI) for acute myeloid leukemia (AML) with a specific biomarker,
FLT3
mutation, marking the introduction of targeted therapy for this notoriously difficult-to-treat type of leukemia.
Read More ›
Discussing Costs with Your Patient Can Reduce Financial Toxicity
By
Chase Doyle
Financial Support
,
Financial Toxicity
With healthcare premiums on the rise and out-of-pocket costs skyrocketing, almost every person diagnosed with cancer is at risk for being underinsured, but this threat extends beyond a patient’s bank balance.
Read More ›
The Samfund Provides Financial Support for Young Adult Cancer Survivors
By
Meg Barbor, MPH
Financial Support
Cancer care is not cheap, but for young adults with cancer, the cost of care goes far beyond medical bills, according to Samantha Watson, MBA, 2-time young adult cancer survivor and Co-Founder and CEO of the Samfund. Few resources in the United States are dedicated specifically to helping patients recover financially from cancer.
Read More ›
The Patient Voice Is Key to Value-Based Care
By
Gail Thompson
Value-Based Care
“It’s the disease of not listening that I am troubled with,” a quote attributed to King Henry IV, kicked off a spirited panel discussion on the importance of incorporating the patient’s voice during treatment. Experts addressed these challenges at the 2018 Association of Community Cancer Centers Annual Meeting & Cancer Center Business Summit on March 16, 2018, in Washington, DC.
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes